Document is current
Any future updates will be listed below
-
Authors
Russell, Brian M.
Boussi, Leora
Bellmunt, Joaquim
- License Information
-
More Information
Article History
Accepted: 11 March 2022
First Online: 28 March 2022
Declarations
:
: No funding was received in support of this article.
: Joaquim Bellmunt has grants pending or has received grants from Pfizer, MSD, and Takeda. He has received consulting fees or honorarium from Merck, Genentech, Astra Zeneca, Pfizer, and MSD. He has stock or stock options in Rainer Therapeutics, and he receives royalties from UpToDate. Brain M. Russell and Leora Boussi have no relevant conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: BMR drafted and wrote the manuscript with the assistance of JB and LB. All authors reviewed, revised, and contributed to the final manuscript. All authors approved the final manuscript prior to submission.
